{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:03:42Z","timestamp":1771315422288,"version":"3.50.1"},"reference-count":27,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    Whether letermovir benefits high\u2010risk HLA\u2010mismatched allogeneic hematopoietic stem cell transplantation (allo\u2010HSCT), particularly with GIAC\u2010based conditioning, is not well studied. In this retrospective real\u2010world analysis, we evaluated the clinical benefits of letermovir in CMV IgG\u2010positive recipients undergoing HLA\u2010mismatched allo\u2010HSCT (year 2011\u20132022) using overlap propensity score (OPS) weighting, with a prespecified subgroup included haploidentical HSCT (haplo\u2010HSCT) with modified GIAC (mGIAC). Among 411 transplants, 105 received letermovir, including 39 of 132 patients following the mGIAC protocol. Letermovir significantly reduced day\u2009+\u2009180 CMV DNAemia (43.4% vs 83.2%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and CMV DNAemia\/disease (44.7% vs 83.4%; HR 0.33;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001), with a nonsignificant decrease in CMV disease (4.7% vs 14.2%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.101). Day\u2009+\u2009180 and +360 survival did not differ between groups. In mGIAC haplo\u2010HSCT, letermovir likewise lowered day\u2009+\u2009180 CMV DNAemia (47.5% vs 82.3%;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.023) and CMV DNAemia\/disease (50.9% vs 83.0%; HR 0.40;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.028) without reducing CMV disease. On multivariable analyses, age\u2009\u2265\u200945\u2009years and nonuse of letermovir independently increased CMV DNAemia\/disease risk in both the overall and mGIAC haplo\u2010HSCT cohorts. Overall survival and non\u2010relapse mortality (NRM) were unaffected by letermovir, probably reflecting effective preemptive management and the study\u2019s overlap\u2010weighted design. Based on our results, letermovir prophylaxis can effectively reduce CMV DNAemia\/disease in HLA\u2010mismatched and mGIAC haplo\u2010HSCT, and may serve as a standard of care for these high\u2010risk patients.\n                  <\/jats:p>","DOI":"10.1002\/cpt.70155","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:09:56Z","timestamp":1764922196000},"page":"773-781","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Letermovir Prophylaxis for\n                    <scp>CMV DNAemia<\/scp>\n                    \/Disease after\n                    <scp>HLA<\/scp>\n                    \u2010Mismatched\n                    <scp>HSCT<\/scp>\n                    : A Retrospective Real\u2010World Analysis with Overlap Propensity Score Weighting"],"prefix":"10.1002","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6930-9261","authenticated-orcid":false,"given":"Yi\u2010Che","family":"Huang","sequence":"first","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"Department of Pharmacy Taipei Medical University, Shuang Ho Hospital  New Taipei City Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0850","authenticated-orcid":false,"given":"Shu\u2010Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"School of Pharmacy, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"Department of Pharmacy National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-8766","authenticated-orcid":false,"given":"Xavier Cheng\u2010Hong","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-6374","authenticated-orcid":false,"given":"Jia\u2010Hau","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematological Oncology National Taiwan University Cancer Center  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-0019","authenticated-orcid":false,"given":"Ming","family":"Yao","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1660-9120","authenticated-orcid":false,"given":"Fei\u2010Yuan","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Graduate Institute of Clinical Pharmacy, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"School of Pharmacy, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"Department of Pharmacy National Taiwan University Hospital  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1816-9010","authenticated-orcid":false,"given":"Yee\u2010Chun","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine National Taiwan University  Taipei Taiwan"},{"name":"Division of Infectious Diseases, Department of Internal Medicine National Taiwan University Hospital  Taipei Taiwan"},{"name":"National Institute of Infectious Diseases and Vaccinology National Health Research Institute  Miaoli County Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7965-7579","authenticated-orcid":false,"given":"Bor\u2010Sheng","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine National Taiwan University Hospital  Taipei Taiwan"},{"name":"Department of Hematological Oncology National Taiwan University Cancer Center  Taipei Taiwan"},{"name":"School of Medicine, College of Medicine National Taiwan University  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"e_1_2_11_1_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8050685"},{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706640"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13866"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-04362-2"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0730-y"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-01082-z"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1064"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab298"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-023-05474-1"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2024.02.005"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.03.005"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-6367(21)00115-9"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2042686"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152116"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac043"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.07.004"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-552984"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw668"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_2_11_22_1","first-page":"6551","article-title":"Risk factors for cytomegalovirus infection after allogeneic hematopoietic cell transplantation in malignancies: proposal for classification","volume":"37","author":"Dziedzic M.","year":"2017","journal-title":"Anticancer Res"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9630-7"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.05.029"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13096"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.128"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041097"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.70155","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.70155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T07:10:39Z","timestamp":1771312239000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.70155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1002\/cpt.70155"],"URL":"https:\/\/doi.org\/10.1002\/cpt.70155","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-08-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}